Your browser doesn't support javascript.
loading
A PI3K p110α-selective inhibitor enhances the efficacy of anti-HER2/neu antibody therapy against breast cancer in mice.
Choi, Jae-Hyeog; Kim, Ki Hyang; Roh, Kug-Hwan; Jung, Hana; Lee, Anbok; Lee, Ji-Young; Song, Joo Yeon; Park, Seung Jae; Kim, Ilhwan; Lee, Won-Sik; Seo, Su-Kil; Choi, Il-Whan; Fu, Yang-Xin; Yea, Sung Su; Park, SaeGwang.
Affiliation
  • Choi JH; Department of Microbiology and Immunology, Inje University College of Medicine, Busan, Republic of Korea.
  • Kim KH; Department of Internal Medicine, Inje University College of Medicine, Busan, Republic of Korea.
  • Roh KH; Department of Microbiology and Immunology, Inje University College of Medicine, Busan, Republic of Korea.
  • Jung H; Department of Microbiology and Immunology, Inje University College of Medicine, Busan, Republic of Korea.
  • Lee A; Department of Surgery, Inje University College of Medicine, Busan, Republic of Korea.
  • Lee JY; Department of Internal Medicine, Inje University College of Medicine, Busan, Republic of Korea.
  • Song JY; Department of Pathology, Dongnam Institute of Radiological and Medical Sciences, Busan, Republic of Korea.
  • Park SJ; Department of Internal Medicine, Inje University College of Medicine, Busan, Republic of Korea.
  • Kim I; Department of Internal Medicine, Inje University College of Medicine, Busan, Republic of Korea.
  • Lee WS; Department of Internal Medicine, Inje University College of Medicine, Busan, Republic of Korea.
  • Seo SK; Department of Microbiology and Immunology, Inje University College of Medicine, Busan, Republic of Korea.
  • Choi IW; Department of Microbiology and Immunology, Inje University College of Medicine, Busan, Republic of Korea.
  • Fu YX; The Department of Pathology and Immunology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Yea SS; Department of Biochemistry, Inje University College of Medicine, Busan, Republic of Korea.
  • Park S; Department of Microbiology and Immunology, Inje University College of Medicine, Busan, Republic of Korea.
Oncoimmunology ; 7(5): e1421890, 2018.
Article de En | MEDLINE | ID: mdl-29721370
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Prognostic_studies Langue: En Journal: Oncoimmunology Année: 2018 Type de document: Article Pays de publication: États-Unis d'Amérique
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Prognostic_studies Langue: En Journal: Oncoimmunology Année: 2018 Type de document: Article Pays de publication: États-Unis d'Amérique